The FDA review process: Obtaining premarket approval for the PAPNET testing system

被引：0
|
作者：
Mango, LJ
机构：
来源：
ACTA CYTOLOGICA | 1996年 / 40卷 / 01期
关键词：
cervical smears; image analysis; computer-assisted; mass screening; laboratory diagnosis;
D O I：
暂无
中图分类号：
R36 [病理学];
学科分类号：
100104 ;
摘要：
引用
收藏
页码：138 / 140
页数：3
相关论文
共 50 条
  • [41] 2014 in review: FDA approval of new drugs
    Kinch, Michael S.
    DRUG DISCOVERY TODAY, 2017, 22 (04) : 620 - 624
  • [42] Strength of Study Evidence Examined by the FDA in Premarket Approval of Cardiovascular Devices (vol 302, pg 2679, 2009)
    Dhruva, S. S.
    Bero, L. A.
    Redberg, R. F.
    JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 2010, 303 (05): : 422 - 422
  • [43] Modifications to High-Risk Ophthalmic Devices Following Initial FDA Premarket Approval, 1979-2015
    Gopal, Anand
    Rathi, Vinay K.
    Teng, Christopher
    Del Priore, Lucian V.
    Ross, Joseph S.
    INVESTIGATIVE OPHTHALMOLOGY & VISUAL SCIENCE, 2017, 58 (08)
  • [44] 2015 in review: FDA approval of new drugs
    Kinch, Michael S.
    DRUG DISCOVERY TODAY, 2016, 21 (07) : 1046 - 1050
  • [45] Premarket Approval Through the 510(k) Process: Lessons from the Translation Process of Magnetic Resonance Elastography
    Ortiz, Jaime A. Aponte
    Konik, Ewa
    Eckert, Elizabeth C.
    Pepin, Kay M.
    Greenberg-Worisek, Alexandra
    CTS-CLINICAL AND TRANSLATIONAL SCIENCE, 2018, 11 (05): : 447 - 449
  • [46] 2024 in Review: FDA Approval of New Medicines
    Kinch, Michael S.
    Kraft, Zachary
    Schwartz, Tyler
    DRUG DISCOVERY TODAY, 2025, 30 (04)
  • [47] Flavoured pod attachments score big as FDA fails to enforce premarket review
    Hemmerich, Natalie
    TOBACCO CONTROL, 2020, 29 (E1) : E129 - E129
  • [48] The FDA approval process for medical devices: an inherently flawed system or a valuable pathway for innovation?
    Fargen, Kyle M.
    Frei, Donald
    Fiorella, David
    McDougall, Cameron G.
    Myers, Philip M.
    Hirsch, Joshua A.
    Mocco, J.
    JOURNAL OF NEUROINTERVENTIONAL SURGERY, 2013, 5 (04) : 269 - 275
  • [49] Blood substitutes move through FDA approval process
    Gwynne, P
    R&D MAGAZINE, 1996, 38 (08): : 19 - 20
  • [50] Surrogate endpoints and FDA's accelerated approval process
    Fleming, TR
    HEALTH AFFAIRS, 2005, 24 (01) : 67 - 78
12345